These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21204217)

  • 1. Clinical manifestations of the deletion of Down syndrome critical region including DYRK1A and KCNJ6.
    Yamamoto T; Shimojima K; Nishizawa T; Matsuo M; Ito M; Imai K
    Am J Med Genet A; 2011 Jan; 155A(1):113-9. PubMed ID: 21204217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial trisomy 21 with or without highly restricted Down syndrome critical region (HR-DSCR): report of two new cases and reanalysis of the genotype-phenotype association.
    Pelleri MC; Locatelli C; Mattina T; Bonaglia MC; Piazza F; Magini P; Antonaros F; Ramacieri G; Vione B; Vitale L; Seri M; Strippoli P; Cocchi G; Piovesan A; Caracausi M
    BMC Med Genomics; 2022 Dec; 15(1):266. PubMed ID: 36544206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial trisomy 21 map: Ten cases further supporting the highly restricted Down syndrome critical region (HR-DSCR) on human chromosome 21.
    Pelleri MC; Cicchini E; Petersen MB; Tranebjaerg L; Mattina T; Magini P; Antonaros F; Caracausi M; Vitale L; Locatelli C; Seri M; Strippoli P; Piovesan A; Cocchi G
    Mol Genet Genomic Med; 2019 Aug; 7(8):e797. PubMed ID: 31237416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly.
    Møller RS; Kübart S; Hoeltzenbein M; Heye B; Vogel I; Hansen CP; Menzel C; Ullmann R; Tommerup N; Ropers HH; Tümer Z; Kalscheuer VM
    Am J Hum Genet; 2008 May; 82(5):1165-70. PubMed ID: 18405873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A.
    Bronicki LM; Redin C; Drunat S; Piton A; Lyons M; Passemard S; Baumann C; Faivre L; Thevenon J; Rivière JB; Isidor B; Gan G; Francannet C; Willems M; Gunel M; Jones JR; Gleeson JG; Mandel JL; Stevenson RE; Friez MJ; Aylsworth AS
    Eur J Hum Genet; 2015 Nov; 23(11):1482-7. PubMed ID: 25920557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies.
    Ji J; Lee H; Argiropoulos B; Dorrani N; Mann J; Martinez-Agosto JA; Gomez-Ospina N; Gallant N; Bernstein JA; Hudgins L; Slattery L; Isidor B; Le Caignec C; David A; Obersztyn E; Wiśniowiecka-Kowalnik B; Fox M; Deignan JL; Vilain E; Hendricks E; Horton Harr M; Noon SE; Jackson JR; Wilkens A; Mirzaa G; Salamon N; Abramson J; Zackai EH; Krantz I; Innes AM; Nelson SF; Grody WW; Quintero-Rivera F
    Eur J Hum Genet; 2015 Nov; 23(11):1473-81. PubMed ID: 25944381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21.
    Lyle R; Béna F; Gagos S; Gehrig C; Lopez G; Schinzel A; Lespinasse J; Bottani A; Dahoun S; Taine L; Doco-Fenzy M; Cornillet-Lefèbvre P; Pelet A; Lyonnet S; Toutain A; Colleaux L; Horst J; Kennerknecht I; Wakamatsu N; Descartes M; Franklin JC; Florentin-Arar L; Kitsiou S; Aït Yahya-Graison E; Costantine M; Sinet PM; Delabar JM; Antonarakis SE
    Eur J Hum Genet; 2009 Apr; 17(4):454-66. PubMed ID: 19002211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DYRK1A mutations in two unrelated patients.
    Ruaud L; Mignot C; Guët A; Ohl C; Nava C; Héron D; Keren B; Depienne C; Benoit V; Maystadt I; Lederer D; Amsallem D; Piard J
    Eur J Med Genet; 2015 Mar; 58(3):168-74. PubMed ID: 25641759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic reanalysis of partial trisomy 21 cases with or without Down syndrome suggests a small region on 21q22.13 as critical to the phenotype.
    Pelleri MC; Cicchini E; Locatelli C; Vitale L; Caracausi M; Piovesan A; Rocca A; Poletti G; Seri M; Strippoli P; Cocchi G
    Hum Mol Genet; 2016 Jun; 25(12):2525-2538. PubMed ID: 27106104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible genes responsible for developmental delay observed in patients with rare 2q23q24 microdeletion syndrome: Literature review and description of an additional patient.
    Shimojima K; Okamoto N; Yamamoto T
    Congenit Anom (Kyoto); 2017 Jul; 57(4):109-113. PubMed ID: 27957763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdeletion of the Down syndrome critical region at 21q22.
    Fujita H; Torii C; Kosaki R; Yamaguchi S; Kudoh J; Hayashi K; Takahashi T; Kosaki K
    Am J Med Genet A; 2010 Apr; 152A(4):950-3. PubMed ID: 20358607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered chromosome-based genetic mapping establishes a 3.7 Mb critical genomic region for Down syndrome-associated heart defects in mice.
    Liu C; Morishima M; Jiang X; Yu T; Meng K; Ray D; Pao A; Ye P; Parmacek MS; Yu YE
    Hum Genet; 2014 Jun; 133(6):743-53. PubMed ID: 24362460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
    Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
    Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Characterization of the Highly Restricted Down Syndrome Critical Region on 21q22.13: New
    Antonaros F; Pitocco M; Abete D; Vione B; Piovesan A; Vitale L; Strippoli P; Caracausi M; Pelleri MC
    Front Genet; 2021; 12():770359. PubMed ID: 34956324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial 4.3 Mb duplication of 21q22 sheds new light on the Down syndrome critical region.
    Ronan A; Fagan K; Christie L; Conroy J; Nowak NJ; Turner G
    J Med Genet; 2007 Jul; 44(7):448-51. PubMed ID: 17237124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A patient with Down syndrome with a de novo derivative chromosome 21.
    Cetin Z; Yakut S; Mihci E; Manguoglu AE; Berker S; Keser I; Luleci G
    Gene; 2012 Oct; 507(2):159-64. PubMed ID: 22827956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells.
    Park J; Oh Y; Yoo L; Jung MS; Song WJ; Lee SH; Seo H; Chung KC
    J Biol Chem; 2010 Oct; 285(41):31895-906. PubMed ID: 20696760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two cases of partial trisomy 21 (pter-q22.1) without the major features of Down syndrome.
    Kondo Y; Mizuno S; Ohara K; Nakamura T; Yamada K; Yamamori S; Hayakawa C; Ishii T; Yamada Y; Wakamatsu N
    Am J Med Genet A; 2006 Feb; 140(3):227-32. PubMed ID: 16411203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous deletion of 21q22.2 in a patient with hypotonia, developmental delay, cortical visual impairment, and retinopathy.
    Hildebrandt C; Fulton A; Rodan LH
    Am J Med Genet A; 2021 Feb; 185(2):555-560. PubMed ID: 33170561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient with partial trisomy 21 and 7q deletion expresses mild Down syndrome phenotype.
    Papoulidis I; Papageorgiou E; Siomou E; Oikonomidou E; Thomaidis L; Vetro A; Zuffardi O; Liehr T; Manolakos E; Vassilis P
    Gene; 2014 Feb; 536(2):441-3. PubMed ID: 24334122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.